Vincent Medical Holdings (HKSE:01612) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:01612 Vincent Medical Holdings Ltd HKSE:01612
49 GF Score
Price HK$0.68
GF Value HK$0.58
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Vincent Medical Holdings Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Vincent Medical Holdings Valuation Rank Related Terms

HKSE:01612
49GF Score
Vincent Medical Holdings Ltd HKSE:01612
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Vincent Medical Holdings (HKSE:01612) Overvalued in 2026?

Based on GuruFocus' analysis, Vincent Medical Holdings stock appears to be overvalued. The current stock price of HK$0.68 is trading 17.2% above its estimated GF Value™ of HK$0.58. GuruFocus considers Vincent Medical Holdings to be Modestly Overvalued.

Key valuation signals for HKSE:01612:

  • Valuation Rank:
  • GF Value™: HK$0.58 vs. price of HK$0.68 (17.2% above fair value)
  • GF Score™: 49/100 with 4 warning signs

No single metric tells the full story. See the HKSE:01612 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vincent Medical Holdings Business Description

Address 22 Tak Fung Street, Units 1604-07A, 16th Floor, Two Harbourfront, Hung Hom, Kowloon, Hong Kong, HKG
Vincent Medical Holdings Ltd is an investment holding company engaged in the manufacturing and selling of medical devices focusing on imaging disposable products on an OEM basis to one of the world's diagnostic imaging solutions providers. The company operates in two segments: OEM (original equipment manufacturing) and OBM (original brand manufacturing). The OEM segment manufactures products as per the customer's requirements. The OBM segment includes research, development, manufacturing, marketing, and sales of medical devices under the Inspired Medical, and Hand of Hope brands. The geographical segments of the company includes the United States, Spain, the PRC, Japan, Costa Rica, the Netherlands, Germany, and Others. It derives its maximum revenue from Spain.
49GF Score

Get the complete analysis for HKSE:01612

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.68
Price
HK$0.58
GF Value